Luchino Chessa

Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis

Patrizia Farci, Tania Roskams, Luchino Chessa et al. · Gastroenterology · 2004 · 294 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

Patrizia Farci, R Strazzera, Harvey J. Alter et al. · Proceedings of the National Academy of Sciences · 2002 · 203 citations

Life Sciences, Genetics, Infectious Diseases +17

Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience

Roberto Littera, Marcello Campagna, Silvia Deidda et al. · Frontiers in Immunology · 2020 · 137 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Ataxia with oculomotor apraxia type 2

Chiara Criscuolo, Luchino Chessa, Silvia Di Giandomenico et al. · Neurology · 2006 · 121 citations

Life Sciences, Genetics, Neurology +14

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Loreta A. Kondili, Giovanni Battista Gaeta, Maurizia Rossana Brunetto et al. · PLoS ONE · 2017 · 114 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11